Bevacizumab-induced hypertension: pathogenesis and management
KN Syrigos, E Karapanagiotou, P Boura, C Manegold… - BioDrugs, 2011 - Springer
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
Bevacizumab-induced hypertension: pathogenesis and management.
KN Syrigos, E Karapanagiotou, P Boura… - … and Gene Therapy, 2011 - europepmc.org
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
Bevacizumab-induced hypertension: pathogenesis and management
KN Syrigos, E Karapanagiotou, P Boura, C Manegold… - BioDrugs, 2011 - go.gale.com
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
Bevacizumab-Induced Hypertension
KN Syrigos, E Karapanagiotou, P Boura, C Manegold… - BioDrugs, 2011 - infona.pl
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
Bevacizumab-Induced Hypertension
KN Syrigos, E Karapanagiotou, P Boura… - …, 2011 - search.proquest.com
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
[引用][C] Bevacizumab-Induced Hypertension
KN Syrigos, E Karapanagiotou, P Boura, C Manegold… - BioDrugs, 2011 - cir.nii.ac.jp
Bevacizumab-Induced Hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ
[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士 …
[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士 …
Bevacizumab-induced hypertension: pathogenesis and management
KN Syrigos, E Karapanagiotou… - … and gene therapy, 2011 - pubmed.ncbi.nlm.nih.gov
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
[PDF][PDF] Bevacizumab-Induced Hypertension
KN Syrigos, E Karapanagiotou, P Boura, C Manegold… - Biodrugs, 2011 - researchgate.net
Bevacizumab, a recombinant humanized monoclonal antibody targeting the vascular
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …
endothelial growth factor (VEGF), has been approved in the US as first-and second-line …